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Development/Plasticity/Repair
Fasciclin II Signals New Synapse Formation through
Amyloid Precursor Protein and the Scaffolding Protein
dX11/Mint
James Ashley,* Mary Packard,* Bulent Ataman, and Vivian Budnik
Department of Neurobiology, University of Massachusetts Medical School, Worcester, Massachusetts 01605-2324
Cell adhesion molecules (CAMs) have been universally recognized for their essential roles during synapse remodeling. However, the
downstream pathways activated by CAMs have remainedmostly unknown. Here, we used theDrosophila larval neuromuscular junction
to investigate thepathways activatedbyFasciclin II (FasII), a transmembraneCAMof the Ig superfamily, during synapse remodeling.We
show that the ability of FasII to stimulate or to prevent synapse formation depends on the symmetry of transmembrane FasII levels in the
presynaptic and postsynaptic cell and requires the presence of the fly homolog of amyloid precursor protein (APPL). In turn, APPL is
regulatedbydirect interactionswith thePDZ(postsynapticdensity-95/Discs large/zonaoccludens-1)-containingproteindX11/Mint/Lin-
10, which also regulates synapse expansion downstream of FasII. These results provide a novel mechanism by which cell adhesion
molecules are regulated and provide fresh insights into the normal operation of APP during synapse development.
Key words: Fasciclin II; amyloid precursor protein; X11; adhesion; signaling; Drosophila; neuromuscular junction
Introduction
Although homophilic cell adhesion molecules (CAMs) of the Ig
superfamily (IgCAMs) play critical roles in synapse plasticity
(Murase and Schuman, 1999; Huntley, 2002; Packard et al., 2003;
Welzl and Stork, 2003), the molecular mechanisms by which
IgCAMs regulate synapse dynamics remain poorly understood
(Garcia-Alonso et al., 1995; Beggs et al., 1997; Schmid et al.,
1999). Mice deficient for the mammalian IgCAM neural CAM
(NCAM) show impaired spatial memory as well as reduced long-
term potentiation (Luthl et al., 1994;Muller et al., 1996). InAply-
sia, long-term facilitation of the gill- and siphon-withdrawal re-
flex results in the formation of new synaptic connections between
the presynaptic siphon-sensory neuron and the target cells. Un-
derlying this process is the downregulation of apCAM, anAplysia
IgCAM, in a manner that involves mitogen-activated protein ki-
nase (MAPK) and a ubiquitin-dependent degradation pathway
(Bailey et al., 1992, 1997).
At the Drosophila neuromuscular junction (NMJ), as muscle
fibers increase in size, synaptic efficacy is maintained by the ex-
pansion of the synaptic arbor, which continuously sprouts new
synaptic boutons throughout development (Packard et al., 2003).
This expansion is regulated by local changes in Fasciclin II (FasII)
levels by a process that involves presynaptic activity, changes in
FasII clustering, MAPK pathway-dependent FasII downregula-
tion, and changes in FasII exocytosis (Budnik et al., 1990; Schus-
ter et al., 1996a; Thomas et al., 1997; Koh et al., 1999, 2002;
Mathew et al., 2003).
A widely acceptedmodel posits that enhanced FasII-mediated
cell adhesion constrains synaptic growth, whereas decreased
FasII-mediated adhesion partially lifts this constraint, allowing
for new synapses to form (Schuster et al., 1996a; Mayford and
Kandel, 1999). Although this model is consistent with the obser-
vations from the above studies, it has not yet been tested fully.
Indeed, almost nothing is known about the signaling mecha-
nisms that may be activated by FasII-mediated cell adhesion.
Moreover, as with other CAMs, the presence of an intracellular
domain suggests that the ability of transmembrane FasII tomod-
ulate synapse formation may also involve the activation of intra-
cellular signaling mechanisms (Biederer et al., 2002; Panicker et
al., 2003).
Here, we demonstrate that FasII requires the fly homolog of
amyloid precursor protein (APPL) to regulate synaptic growth
and that its influence on synaptic bouton formation cannot be
simply explained in terms of adhesion but by additional signaling
through APPL. We show that FasII and APPL are in the same
protein complex in vivo and that FasII–APPL signaling depends
on interactions with the APPL-binding protein dX11/Mint/Lin-
10/dX11L. Furthermore, we find that enhancement of new syn-
apse formation depends on a balance of FasII levels at both sides
of the synapse rather than a change in absolute levels, as suggested
previously. Conversely, an imbalance of FasII levels at either side
of the synapse interferes with new synapse formation and leads to
gross abnormalities in bouton structure, including microtubule
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tangles, membranous inclusions, and abnormal APPL deposits.
These studies unravel a signaling pathway activated by FasII dur-
ing synapse formation and establish a link between two impor-
tant modulators of synapse growth: FasII and APPL.
Materials andMethods
Fly strains. Flies were reared in standardDrosophilamedium. The follow-
ingmutant stocks were used: hypomorph fasIIe76 (Schuster et al., 1996a),
null alleleAppld (Luo et al., 1992), double-mutantAppld fasIIe76 obtained
by recombination, P[UM-8095-3] (Bloomington Stock Center, Bloom-
ington, IN), andDf(1)BK10 (Bloomington Stock Center), a deficiency of
the dX11 region. We used the following upstream activator sequence
(UAS)–APPL strains [described by Torroja et al. (1999)]: UAS–APPLSD,
containing a form of APPL that cannot be proteolytically processed,
UAS–APPLC in which the intracellular domain of APPL is deleted, and
UAS–APPLCi, in which the cytoplasmic internalization sequence GY-
ENPTY has been removed. We also used the following: dX11, UAS–
dX11PTB, in which the phosphotyrosine-binding (PTB) domain had
been deleted, and the FasII UAS strain UAS–FasII–glycosylphosphatidy-
linositol (GPI) (see below). Gal4 activator strains used to drive
motoneuron-specific expression of APPL and FasII were C164, which
has Gal4 expression in type I motoneurons during larval development
(Torroja et al., 1999), and C380, which has Gal4 expression in type I
motoneurons (Koh et al., 1999). For expression of transgenes in body-
wall muscles, we used the Gal4 drivers BG487 and C57 (Budnik et al.,
1996).
Generation of transgenic flies. To generate UAS–dX11, Drosophila
dX11 cDNA was digested with NotI and KpnI, and the resulting insert,
containing the entire dX11 coding region, was directly cloned into
pUAST vector for germline transformation (Spradling, 1986). To gener-
ate dX11 lacking the APP-binding PTB domain (dX11PTB), site-
directed mutagenesis was performed using the Stratagene (La Jolla, CA)
QuikChange kit. Briefly, oligos were used to introduceXho sites on either
side of the PTB domain coding sequences (amino acids 766–986), the
PTB domain was digested out, and sticky ends religated before subclon-
ing into pUAST. To generate a UAS–GPI-linked FasII, cDNA LP01422
was digested with EcoRI and ligated into the pUAST vector.
Immunocytochemistry and antibody production. Immunocytochemis-
try and laser-scanning confocal image acquisition and analysis were as
performed by Budnik et al. (1996) using a Bio-Rad (Hercules, CA)
MRC600 or a Zeiss (Oberkochen, Germany) LSM confocal microscope
and Zeiss PASCAL 3.0 software. To quantify synapse number, third in-
star body-wall muscle preparations were labeled with a neuronal marker
(anti-HRP, which cross-reacts with several presynaptic membrane anti-
gens, thus labeling the entire presynaptic arbor), and boutons were
counted at muscles 6 and 7 of abdominal segment 3. To quantify the
number of buds, the following criteria were used to identify buds: (1)
buds were much smaller than the parent boutons, and (2) they appeared
to sprout from a neighboring “parent” bouton ofmature bouton size. To
measure muscle surface, the width and length of muscles 6 and 7 were
measured under epifluorescence using a calibrated ocular grid. For the
expression of FasII, dX11, or APPL variants using the UAS/Gal4 system
(Brand and Perrimon, 1993), crosses and rearing of larvae were per-
formed at 29°C to maximize levels of Gal4 expression. Controls at this
temperature were also performed for wild-type, homozygous Gal4
strains, homozygous UAS–APPL strains, and Gal4/UAS–LacZ heterozy-
gotes. No significant differences in bouton number were observed in
these controls. The number of buds and boutons was expressed (mean
SEM) and compared using the Student’s t test. To quantify APPL levels
inside a bouton, a single confocal slice at the boutonmidlinewas selected,
and APPL fluorescence intensity in the ring of HRP staining at the bou-
ton membrane (APPLm) was measured. APPL fluorescence at the inter-
nal region of the bouton (APPLi), the area circumscribed by the ring of
HRP staining, was then added to the intensity value by using the histo-
gram function of the Zeiss LSM software. Then background intensity,
obtained bymeasuringAPPL fluorescence intensity in surroundingmus-
cle, was subtracted, after normalizing the intensity measurements to sur-
face area. Numbers were expressed as percentage of total APPL fluores-
cence (normalized APPLi/normalized APPLm plus APPLi). The
following antibodies were used to label synaptic terminals: FITC- or
Texas Red-conjugated anti-HRP (1:200), anti-FasII (1:3500) (Koh et al.,
1999), anti-APPL952 (1:500) (Torroja et al., 1996), anti-dX11 (1:100; see
below), anti-tubulin (1:1000; Sigma, St. Louis, MO), and monoclonal
antibody 22C10 (1:100; a gift from S. Benzer, Developmental Studies
Hybridoma Bank, University of Iowa, Iowa City, IA. Secondary antibod-
ies (Jackson ImmunoResearch, West Grove, PA) were used at 1:200.
Anti-dX11 antibodies were generated by immunizing rats and rabbits
with bacterially generated and affinity-purified His-tagged protein
(dX11 N-terminal amino acids 137–266), produced using the pET Sys-
tem (Novagen, Madison, WI). The rabbit antiserum was subsequently
affinity purified (Tang, 1993).
Immunoprecipitations. For immunoprecipitations, 20–40 body-wall
muscle preparations per genotype were homogenized at 4°C in radioim-
munoprecipitation assay (RIPA) buffer containing protease inhibitors
and 100 m Na3VO4. After centrifugation (3000  g for 5 min), the
supernatant was precleared with Protein A- or Protein A/G-agarose
beads for 1 h. Cleared lysate was subsequently incubated with beads
bound to rat anti-dX11 or rabbit anti-APPL952 at 4°C for 1–2 h and then
washed three times with PBS. Beads and the bound immunocomplexes
were then collected by centrifugation, washed three times with RIPA
buffer, and boiled in loading buffer. Proteins were separated in an 8%
SDS-PAGE gel, transferred to Immobilon-P (Millipore, Billerica, MA)
nylon membrane, and sequentially blotted with rabbit anti-APPL952
(1:1000), rat anti-dX11N1 (1:1000),mouse anti-tubulin (1:5000; Sigma),
and rabbit anti-FasII (1:1000).
Schneider cell transfection. dX11 and fasII cDNAs were cloned into the
pAcV5/HisB vector (Invitrogen, Carlsbad, CA) for transfections. Dro-
sophila Schneider (S2) cells were cultured inHYQ SFX-Insect cell culture
medium (HyClone, Logan, UT) containing 10% FBS, penicillin (100
U/l), and streptomycin (100g/l). Three wells (2ml each) per sample
of 60–80% confluent S2 cells were transfected with 1.5g of DNA using
Cellfectin (Invitrogen). Thirty-six hours after transfection, cells were
harvested, resuspended in 300 l of RIPA buffer, and homogenized, and
immunoprecipitations were performed as described above for body-wall
muscles. For RNA interference (RNAi) experiments, dX11 double-
stranded RNA (dsRNA) was generated using dX11 primers containing a
5T7 polymerase-binding site and applied to S2 cells, as described by
Clemens et al. (2000).
Electronmicroscopy.Ultrastructural analysis was as performed by Jia et
al. (1993), with the exception of the use of 2 mM Mg2 Trump’s fixative
(Torroja et al., 1999). Transverse ultrathin serial sections (70–80 nm)
were cut from ventral longitudinal muscles 6 and 7 at abdominal seg-
ments A3 and A4. Three wild-type (10 boutons), three [FasII, APPL]-pre
(12 boutons), and three [FasII]-pre (eight boutons) samples were used
for this analysis.
Electrophysiology.All experiments were performed onwandering third
instar larvae raised at 29°C. Larvae were dissected under ice-cold
hemolymph-like (HL-3) saline (Stewart et al., 1994) containing 0.3 mM
calcium. Body-wall muscles were visualized under a Zeiss Axiovert 200
using a 40 long-working distance objective and continually superfused
with HL-3 saline containing 0.5 mM calcium at 22°C. Recordings were
done by impaling body-wall muscle 6 in abdominal segment 3 with a
15–20MU` electrode andwere amplified using anAxoclamp 2A amplifier
(Molecular Devices, Union City, CA). Recordings were exported to both
an ITC-16 computer interface (InstruTech, PortWashington, NY) and a
Neuro-Corder (Neurodata Instruments,NewYork,NY) for data storage.
Data were imported via Pulse software (HEKA Electronik, Lambrecht/
Pfalz, Germany) and analyzed using both Mini Analysis software (Syn-
aptosoft, Decatur, GA) and Origin software (OriginLab, Northampton,
MA). Evoked excitatory junctional potentials (EJPs) were induced
through application of a 10-m-diameter lumen glass-suction electrode
to a cut segmental nerve and stimulated with a 1 ms suprathreshold
stimulus at 1 Hz by an S48 stimulator and an SIU-5 stimulus isolation
unit (Grass-Telefactor, West Warwick, RI). Only muscle cells with a
resting potential of 60 to 63 mV were used for analysis, and at least
five cells were analyzed for each genotype. Statistical analysis was per-
formed using the Student’s t test.
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Results
Does FasII constrain synaptic growth?
Previous studies of NMJ expansion have suggested a basic model
of FasII function at the NMJ, in which enhanced FasII-mediated
cell adhesion constrains synaptic growth, whereas decreased
FasII-mediated cell adhesion partially lifts
this constraint, allowing for new synapses
to form (Schuster et al., 1996a,b). In those
studies, FasII levels were decreased by us-
ing hypomorphic fasII alleles as well as
mutations that decrease FasII expression
at the NMJ, which resulted in greater syn-
aptic growth. However, the consequences
on synaptic bouton number of enhancing
FasII expression either presynaptically or
postsynaptically, or both simultaneously,
was not examined in those studies. In sub-
sequent work, Davis et al. (1997) exam-
ined the effects of changing FasII levels in
the stabilization of ectopic innervation.
The main finding in this study was that
increasing FasII in specific muscles during
the embryonic period led to the stabiliza-
tion of inappropriate synaptic connec-
tions, but no such effect was observed
when FasII levels were altered in the
postembryonic period, when most synap-
tic boutons are formed (Davis et al., 1997).
To further explore the above hypothe-
sis, we labeled NMJs at the last stage of
larval development with a presynaptic ter-
minal marker (anti-HRP; see Materials
and Methods), and the degree of NMJ ex-
pansion was determined by counting the
number of synaptic boutons (Budnik et
al., 1990; Gorczyca et al., 1993). In agree-
mentwith the basicmodel, overexpression
of FasII either presynaptically or postsyn-
aptically resulted in a significant decrease
in bouton number (Fig. 1A). Surprisingly,
however, and in contrast to the above
model, we found that when FasII levels
were simultaneously elevated in both the
presynaptic and postsynaptic cells
([FasII]-pre-post), there was a remarkable
increase to150–230% of the number of
synaptic boutons compared with wild
type, depending on the strength of the
Gal4 drivers used to express UAS–FasII
(Fig. 1A). When FasII was simultaneously
decreased in both the presynaptic and
postsynaptic cells in fasIIe76/ heterozy-
gotes, the result was a small but significant
increase in bouton number, as seen in the
studies of Schuster et al. (1996) (Fig. 1A).
These changes in bouton number (and in
all of themutants examined in Fig. 1) were
not attributable to changes in muscle size,
which was indistinguishable from wild-
type controls. Also, because we used Gal4
drivers that drive expression of transgenes
during the postembryonic period, no ec-
topic synapses were observed. Therefore,
changes in bouton number were not the result of defects in tar-
geting and stabilization of ectopic synapses, which occur after
changing FasII levels during initial embryonic synaptogenesis
(Davis et al., 1997). Thus, a simultaneous decrease or a simulta-
neous increase in FasII levels in both the presynaptic and the
Figure 1. FasII signaling through APPL stimulates NMJ growth, and both proteins form a complex in vivo. A–D, Histograms
showing the number of boutons at muscles 6 and 7 (abdominal segment 3) of third instar larvae with different levels of FasII and
APPL. Thenumberof samplesquantified is as follows:wild type,n95; fasIIe76/,n12; [FasII]-pre,n43; [FasII]-post,n
17; [FasII]-pre-post (using theGal4 drivers C380 andBG487),n13; [FasII]-pre-post# (using theGal4 drivers C164 andC57),n
10; Appld, n 49; [APPL]-pre (using Gal4 driver C380), n 14; [APPL]-pre* (using the Gal4 driver C164), n 85; Appld,
fasIIe76/Appld,, n 24; Appld, [FasII]-pre-post (using the Gal4 drivers C164 and C57), n 10; [GPI–FasII]-pre-post (using the
Gal4 drivers C380 and BG487), n 6; [FasII, APPL]-pre-post# (using the Gal4 drivers C380 and BG487), n 27; [FasII, APPL]-pre,
n 25; [FasII, APPLC]-pre, n 10; fasIIe76, [APPL]-pre, n 21.Bouton numbers aremean values SEM. *p	 0.05; ***p	
0.0001. Low- (E–G) andhigh- (I–Q)magnificationviewsof third instar larvalNMJsatmuscles 6and7 stainedwithanti-HRP (E–G,
I, J, L–N, P, Q), the synaptic vesicle marker anti-synapsin (K, L, O, P), and anti-HRP and anti-FasII (Q, inset). E, I–L, Wild type. F,
M–P, Larvae overexpressing only FasII in both presynaptic andpostsynaptic cells.G,Q, Larvae overexpressing bothAPPL and FasII
in both presynaptic and postsynaptic cells. I,M, Stereoscopic images showing budding boutons in wild type (I ) and [FasII]-pre-
post (M ). Note the dramatic increase in budding boutons in larvae overexpressing FasII either alone or in combinationwith APPL.
Scale bars: (inQ) E–G, 50m; I–Q, 8m.H, FasII andAPPL coimmunoprecipitate frombody-wallmuscle extracts. Extractswere
immunoprecipitated with anti-APPL antibodies, and immunoblots were sequentially probed using anti-APPL, anti-FasII, anti-
tubulin (Tub), and anti-spectrin (Spec). Input lanes correspond to 10%of the extract used for immunoprecipitation. Control lanes
correspond to extracts in which antibody was omitted during immunoprecipitation. Note that anti-APPL immunoprecipitates
FasII and that this interaction is specific because no FasII band could be detected in Appld. Molecular weights are indicated in
kilodaltons to the right of each blot. Error bars represent SEM.
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postsynaptic cells results in an increase in bouton number, albeit
to different extents.
An important distinction to be made, however, is that the
striking increase in bouton number that we observed in [FasII]-
pre-post was primarily attributable to proliferation of “satellite”
boutons or buds. In the wild type, NMJs expand in part by
sprouting or budding newboutons (Fig. 1 I, arrow), commonly at
the distal end of a branch (Zito et al., 1999; Packard et al., 2002;
Ruiz-Canada et al., 2004). These buds enlarge and then separate
from the parent bouton, remaining connected only by a thin
process, and eventually grow to become mature boutons. In
NMJs overexpressing FasII in both presynaptic and postsynaptic
cells, the dramatic increase in satellites/buds, 672% over wild
type, was observed at both distal and proximal boutons (Fig.
1M–P, arrows in M). In contrast, satellite number in fasIIe76/
decreased to 33% of the wild-type value [8.6  1.1 in wild type
(n 30) vs 74.5 5.22 in [FasII]-pre-post (n 9) and 2.8 0.6
in fasIIe76/ (n 12)]. To determine whether the buds observed
in [FasII]-pre-post represented an enhancement of the normal
process of bouton budding observed in wild type, we performed
an ultrastructural analysis of buds. We found that buds in
[FasII]-pre-post were similar to those observed in wild type, in-
cluding the distribution of synaptic vesicles, active zones, and
postsynaptic specializations (supplemental Fig. 1, available at
www.jneurosci.org as supplemental material).
The above observations suggest that the influence of FasII on
synaptic growthmay not be purely related to its “adhesive” prop-
erties that are proposed to restrict synapse expansion, but may
also involve the activation of a signaling cascade that promotes
bud formation. This signaling cascade might depend on ho-
mophilic binding between FasII molecules at the presynaptic and
postsynaptic cell, because overproliferation of boutons was ob-
served only after changing FasII levels in both the presynaptic and
the postsynaptic cells (Fig. 1A and below).
Transmembrane FasII isoforms can form dimers through ho-
mophilic interactions that require their extracellular Ig domains,
but FasII also contains a 136 aa intracellular domain (Grennin-
gloh et al., 1991), which may transduce a signal to the intracellu-
lar milieu. To determine whether the increase in bouton number
in [FasII]-pre-post depended on an intact intracellular domain,
we generated transgenic flies carrying the GPI-linked FasII iso-
form (GPI–FasII), in which the intracellular and transmembrane
domains are missing, and expressed it presynaptically and
postsynaptically. No increase in bouton number was observed in
[GPI–FasII]-pre-post, demonstrating that the effect of FasII on
bouton number depended on an intact intracellular domain (Fig.
1A).
FasII requires APPL to modulate synaptic bouton formation
The spectacular increase in bouton buds observed at NMJs over-
expressing FasII at both presynaptic and postsynaptic cells was
highly reminiscent of the phenotype observed in NMJs with in-
creased APPL (Torroja et al., 1999), a presynaptically localized
homolog of APP. Overexpressing APPL in motoneurons results
in an increase in bouton number to250% of wild type, primar-
ily because of an overproliferation of bouton buds, but also be-
cause of a proliferation of mature boutons, whereas a null muta-
tion inAppl,Appld, reduces bouton number (Torroja et al., 1999)
(Fig. 1B,D).
The similarity of the results between overexpression of FasII
and APPL raised the possibility that FasII may activate APPL-
dependentmechanisms that promote synaptic growth.We tested
this possibility by looking for genetic and biochemical interac-
tions betweenAPPL and FasII. In these experiments, wemodified
the levels of both proteins by generating both loss- and gain-of-
function double mutants. As noted, a reduction in FasII levels in
fasIIe76/ resulted in a small but significant increase in bouton
number (Fig. 1B). This increase in bouton number was com-
pletely suppressed in an Appl null mutant background (Appld,
fasIIe76/Appld,), and furthermore, the number of synaptic bou-
tons actually decreased compared with wild type in this double
mutant (Fig. 1B). These data lend support to the notion thatAppl
and fasII genes interact and that the increase in bouton number
observed in fasIIe76/may result from interactions with APPL.
This hypothesis was further tested by simultaneously overex-
pressing FasII in both the presynaptic and postsynaptic cells in
the Appl null mutants (Appld, [FasII]-pre-post). Again, we found
that in the absence of APPL, overexpressing FasII in both the
presynaptic and the postsynaptic cell led to awild-type number of
boutons, in contrast to the twofold increase when APPL levels
were normal (Fig. 1C).
Another phenotype elicited by a symmetric increase or de-
crease in FasII was a rise in the number of NMJ branches (sup-
plemental Fig. 2A, available at www.jneurosci.org as supplemen-
tal material). Again, as in the case of bouton overproliferation,
this phenotype was completely suppressed by the absence of
APPL (supplemental Fig. 2A, available at www.jneurosci.org as
supplemental material).
To determine whether APPL was acting downstream of FasII,
we performed the converse experiment, by determining whether
a severe reduction in FasII function in fasIIe76 homozygotes could
rescue the bouton overproliferation observed by increasingAPPL
levels. However, we found that a decrease in FasII levels in the
presence of elevated APPL ( fasIIe76, [APPL]-pre) did not rescue
the increased bouton number observed in APPL gain-of-
function alone (Fig. 1D). Thus, the increase in bouton number
observed when there is a simultaneous increase or decrease in
presynaptic and postsynaptic FasII levels requires the presence of
APPL, indicating that APPL exerts its effects downstream of FasII
during synaptic bouton growth.
This hypothesis was further confirmed by experiments in
which APPL expression was upregulated in larvae in which FasII
was simultaneously enhanced in both the presynaptic and the
postsynaptic cell ([FasII, APPL]-pre-post). In this case, the in-
crease in bouton number was further potentiated to400% (Fig.
1D,G,Q). Together, the results from the above genetic approach
uncover a novel transduction pathway by which FasII regulates
synapse structure and function through interactions with APPL.
A potential association of FasII and APPL into an endogenous
protein complex was examined by immunoprecipitation assays
using body-wall muscle extracts. We found that antibodies
against APPL coimmunoprecipitated FasII from body-wall mus-
cle extracts, but this was not observed in extracts from Appl null
mutants, demonstrating the specificity of the immunoprecipita-
tion (Fig. 1H). Furthermore, spectrin, which is particularly en-
riched at synaptic boutons (Ruiz-Canada et al., 2004) was not
coprecipitated by APPL antibodies, demonstrating selectivity for
the complex (Fig. 1H). Thus FasII and APPL interact genetically
during NMJ expansion and are present in a biochemical complex
in vivo.
Functional consequences of altering FasII and APPL levels
Although APPL has been shown previously to be involved in the
regulation of synaptic bouton formation (Torroja et al., 1999),
the functional consequences of altering APPL levels have not
been investigated. Similarly, the functional consequences of in-
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creasing bouton number by symmetric changes in FasII in
fasIIe76/ and [FasII]-pre-post are not known (but see Schuster
et al., 1996b). Therefore, we recorded intracellularly from body-
wall muscles and stimulated segmental nerves to visualize EJPs.
In fasIIe76/ animals, EJPs had significantly larger amplitudes
than wild-type controls ( p 	 0.0001) (Fig. 2A,C), possibly re-
flecting the increased number of mature boutons in these mu-
tants. In contrast, EJP amplitude inAppl null mutants was signif-
icantly decreased ( p 	 0.0001), albeit to a smaller extent (Fig.
2A,C). This phenotype may also reflect the decrease in bouton
number observed in this mutant. In agreement with our hypoth-
esis that many of the synaptic functions of FasII may occur
through interactions with APPL, the increased EJP amplitude in
fasIIe76/ was completely suppressed in the absence of APPL in
Appld, fasIIe76/, and furthermore, it was indistinguishable from
Appld mutants (Fig. 2A,C).
Unexpectedly, when FasII was expressed both presynaptically
and postsynaptically, EJP amplitude was significantly decreased
compared with both wild type and Appld (Fig. 2A,C). This may
reflect the fact that much of the synaptic bouton overprolifera-
tion in [FasII]-pre-post is attributable to the formation of imma-
ture boutons or buds. In agreement with this view, overexpress-
ing APPL, which also causes an overproliferation of buds, also
leads to a decrease in EJP amplitude (Fig. 2A,C). As in the case of
fasIIe76/, the [FasII]-pre-post phenotype was completely sup-
pressed by the absence of APPL, and again, EJP amplitudes were
indistinguishable from Appld (Fig. 2A,C). This result demon-
strates that defects in the postsynaptic signal derived from alter-
ing FasII levels depend on APPL.
To determinewhether the defects in EJP amplitudewere likely
to be derived from changes in either presynaptic or postsynaptic
function, or both, we also examined the amplitude and frequency
of miniature EJPs. Although changes in mEJP amplitude are of-
ten attributable to changes in postsynaptic function, changes in
mEJP frequency are associated with changes in presynaptic func-
tion. Furthermore, Drosophila larval NMJs can display compen-
satory mechanisms that may in certain instances adjust presyn-
aptic and postsynaptic responses to maintain synaptic efficacy
(Stewart et al., 1996; Davis and Goodman, 1998; Paradis et al.,
2001). We found that, in Appld, mEJP frequency and mEJP am-
plitude were dramatically increased (Fig. 2B,D–F), perhaps as a
consequence of such a compensatory mechanism. Overall, how-
ever, junctional quantal content (QC  EJP amplitude/mEJP
amplitude), a measure of synaptic efficacy, was still significantly
depressed (Fig. 2F).
In fasIIe76/ mutants, mEJP amplitude was unchanged, and
mEJP frequency was significantly decreased. However, QC was
significantly enhanced (Fig. 2B,D–F). This rise in QC was sup-
pressed by Appld, again suggesting that APPL is required for at
least some of the functional pathways regulated by FasII. Indeed,
changes in QC in [FasII]-pre-post were not rescued by the ab-
sence of APPL (Fig. 2B,D–F). Thus, although all of the structural
and many of the functional defects associated with changes in
FasII levels depend on APPL, these results also suggest that
changes in FasII can alter NMJ function independently of APPL.
Asymmetric changes in FasII expression interfere with
normal synapse development
In contrast to observations in which symmetric changes in FasII
at both the presynaptic and the postsynaptic cell resulted in an
Figure 2. Electrophysiological analysis of APPL and FasII genetic variants. A, Representative traces of evoked EJPs, in which each trace is the average of 400 EJPs, in wild-type; Appld; fasIIe76/;
Appld, fasIIe76/; [FasII]-pre-post; Appld, [FasII]-pre-post; and [APPL]-pre.B, RepresentativemEJP traces of the same genotypes shown inA. C–F, Histograms showingmean SEM of evoked EJP
amplitude (C), mEJP amplitude (D), mEJP frequency (E), and quantal content (F ). A single asterisk indicates significance in relation to wild type; triple carets or triple asterisks indicate p	 0.0001;
double carets or double asterisks indicate p	 0.05. Calibration: A, 10 mV, 20 ms; B, 7 mV, 100 ms. Error bars represent SEM.
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increase in bouton number, we found that
a grossly asymmetric change in FasII levels
brought about by overexpressing FasII in
either the presynaptic or the postsynaptic
cell alone interfered with normal NMJ ex-
pansion.When FasII was increased only in
the presynaptic or the postsynaptic cell,
there was a significant decrease in bouton
number (Fig. 1A). Furthermore, an asym-
metric increase in FasII levels in the pre-
synaptic cell partially suppressed the in-
crease in bouton number observed in the
APPL gain-of-function alone ([FasII,
APPL]-pre) (supplemental Fig. 2B, avail-
able at www.jneurosci.org as supplemental
material). These results, together with the
observation that increasing FasII levels de-
creases bouton number in an asymmetric
manner in either the presynaptic or
postsynaptic cells, suggest that an imbal-
ance in FasII expression in both cells acts
in a dominant-negativemanner that inter-
feres with the ability of APPL to promote
synapse formation or that inhibits APPL
activation by FasII.
This view was supported by the obser-
vation that synapses were dramatically al-
tered not only in number but also in struc-
ture when FasII was asymmetrically
expressed. This was particularly evident when FasII was ex-
pressed presynaptically in the APPL gain-of-function but was
also observed in the presence of normalAPPL (see below). Inwild
type, type I boutons at muscles 6 and 7 consist of strings of bou-
tons, which are relatively homogeneous in size, and are joined by
short neuronal processes (Johansen et al., 1989). In the [FasII,
APPL]-pre gain-of-function double mutants, many type I bou-
tons were strikingly enlarged compared with controls (Fig. 3A,
B,D,H, arrows in B). In addition, these NMJs were characterized
by very long neuritic processes, which were devoid of boutons for
long stretches (Fig. 3B, arrowheads). These “giant” boutons con-
tained internal membranous structures that stained brightly with
the neuronal membrane marker anti-HRP (Fig. 3D,H), and
which contained unusual APPL (Fig. 3, compare E, I with F, J; L,
arrows) and FasII (Fig. 3, compare M, P with N, Q) protein
accumulation.
The above phenotype was not simply attributable to overex-
pressing APPL and FasII at nonphysiologically high levels, be-
cause symmetrically overexpressing FasII in both the presynaptic
and the postsynaptic cell in the presence of increased levels of
APPL ([FasII, APPL]-pre-post) did not result in this phenotype
at the NMJ. However, to further eliminate this possibility, we
expressed APPLC, a form of APPL lacking a domain that is
required for the synapse-promoting function ofAPPL (Torroja et
al., 1999). We found that overexpressing FasII in the presynaptic
cells togetherwithAPPLC([FasII, APPLC]-pre) did not result
in the formation of abnormal synaptic boutons (Fig. 3C) or in
APPL (Fig. 3G,K) and FasII (Fig. 3O,R) deposits. Thus, the phe-
notypes observed in [FasII, APPL]-pre are specific and depend on
an intact APPL cytoplasmic domain.
The phenotypes observed in [FasII, APPL]-pre larvae were
also present, although to a much lesser extent, in boutons over-
expressing only FasII in the presynaptic cell alone in the presence
of normal (endogenous) APPL ([FasII]-pre). These boutons had
internal structures that stained with anti-HRP and that were as-
sociated with abnormal accumulations of APPL (not shown).
These inclusions were virtually never observed in wild-type
boutons.
Formation of microtubule tangles and APPL deposits in
giant boutons
In Alzheimer’s disease, neurofibrillary tangles are composed of
cytoskeletal components including an unusual hyperphosphory-
lated form of the microtubule-associated protein tau (Spillantini
and Goedert, 1998; Selkoe and Podlisny, 2002). Hyperphospho-
rylated tau is unable to promote or maintain microtubule stabil-
ity because, unlike normal tau, this form is unable to bind to
microtubules (Iqbal et al., 1998). The result is the formation of
collections of tangled cytoskeletal filaments throughout the cyto-
plasm of neurons in patients with Alzheimer’s disease and other
disorders associated with senile dementia. Although alterations
in APP processing have beenwidely accepted as playing a key role
in Alzheimer’s pathology, no clear mechanistic connection has
yet beenmade betweenAPP and tangle formation. At the flyNMJ
presynaptic microtubules are associated with the microtubule-
associated protein 1B-related protein Futsch (Hummel et al.,
2000; Roos et al., 2000). Futsch immunoreactivity, as determined
by the monoclonal antibody 22C10, colocalizes with presynaptic
microtubules at wild-type NMJs and is observed as a single fila-
mentous bundle that traverses the center of each NMJ branch
(Fig. 4A–C). At certain boutons, often located at the distal end of
an NMJ branch (terminal boutons), microtubules become un-
bundled, and their association with Futsch is lost (Ruiz-Canada
et al., 2004). We found that, in enlarged [FasII, APPL]-pre bou-
tons, even when the giant bouton was not at the end of a branch,
Futsch appeared defasciculated into multiple filaments that
spread inside the giant boutons (Fig. 4E–G, arrow in F), or
formed large clusters or puncta inside these giant boutons (Fig.
Figure 3. Gross asymmetric changes in FasII levels interfere with APPL-mediated synaptic growth. A–C, Low-magnification
views of third instar larval NMJs at muscles 6 and 7 stained with anti-HRP antibodies in wild type (A), a mutant presynaptically
overexpressing both APPL and FasII (B), and a larva expressing FasII and APPLC presynaptically (C). B, Note the dramatically
enlarged boutons in the [FasII, APPL]-pre (arrows) and the long stretches of neuritic processes lacking varicosities (arrowheads).
D–R, High-magnification single confocal slices through a bouton inwild type (D, E, I,M,P), [FasII, APPL]-pre (H, L, F, J,N,Q), and
[FasII, APPLC]-pre (G, K,O,R). Note the internal inclusions and abnormal APPL accumulations inmutants expressing both FasII
and APPL and the lack of inclusions and APPL accumulations in samples in which a form of APPL lacking the cytoplasmic domain
(C) is expressed. L, Image at highermagnification shows anti-APPL accumulations (arrows) in a [FasII, APPL]-pre bouton.M–R,
High-magnification single confocal sections showing anti-FasII (M–O) and anti-HRP and anti-FasII (P–R) in wild type (M, P),
[FasII, APPL]-pre (N,Q), and [FasII, APPLC]-pre (O,R). Note that the internal FasII-positive inclusions inboutons expressingboth
APPL and FasII only presynaptically is suppressed when the APPL cytoplasmic domain is absent, demonstrating the specificity of
the interaction between APPL and FasII. Scale bars: (in A) A–C, 50m; I, 3m; D–K,M–R, 5m.
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4H–J, arrow in I). The distribution of microtubules, as deter-
mined by staining with antibodies against tubulin, was also
greatly disrupted inside these boutons. In the [FasII, APPL]-pre
larvae, unlike wild type, presynaptic microtubules were found
forming defasciculated tangles that filled the boutons and often
surrounded the APPL-filled internal membrane structures (Fig.
4D,K). As an internal control, postsynaptic microtubules in the
muscle cells were normal in [FasII, APPL]-pre larvae (Fig.
4D,K).
To understand the structural basis for the above phenotypes
ultrastructural studies were conducted. Wild-type boutons are
boundby a presynapticmembrane,which surrounds the synaptic
vesicles, mitochondria, and endosomes (Fig. 5A). In contrast, the
giant boutons were characterized by the presence of many inter-
nal membranes, sometimes arranged into concentric layers (Fig.
5C). Some of the compartments defined by these internal mem-
branes contained synaptic vesicles and mitochondria. However,
active zone T-bars were only observed at the outer perimeter of
these giant boutons (Fig. 5C, arrows).
Another abnormal phenotype observed in [FasII, APPL]-pre
gain-of-function mutants was the presence of an unusually large
number of coated vesicles in both the presynaptic and the
postsynaptic compartments (Fig. 5B,D, arrowheads). Altogether,
these results suggest that asymmetric changes in FasII levels in-
terfere with APPL-dependent stimulation of synapse growth, and
demonstrate a formation of unusual internal membranous and
cytoskeletal tangles, in which APPL aberrantly accumulates.
The stimulation of bouton budding by
FasII and APPL depends on the
cytosolic adaptor protein dX11
The above results are consistent with a
FasII signaling mechanism that depends
on APPL. Our previous studies have dem-
onstrated that the ability of APPL to en-
hance synaptic bouton number depends
on its cytoplasmic domain (Torroja et al.,
1999). Overexpressing APPL results in a
large increase in bouton buds. This prolif-
eration of buds is completely suppressed
when an APPL variant lacking the entire
cytoplasmic region is expressed. Further-
more, expressing an APPL variant
(APPLCi), in which an amino acid se-
quence is deleted at the cytoplasmic region
(GYENPTY), suppresses the overprolif-
eration of buds. These observations have
led to the suggestion that the GYENPTY
sequence is fundamental for the regulation
of bud number (Torroja et al., 1999).
In mammals, the GYENPTY sequence
is conserved and is required for endocyto-
sis of APP (Lai et al., 1998; Perez et al.,
1999). Proteins that bind to theGYENPTY
sequencemodulate APP trafficking and/or
prevent the cleavage of APP at the cell sur-
face (Borg et al., 1996; Sastre et al., 1998;
Sabo et al., 1999; Ando et al., 2001; Taru et
al., 2002; King et al., 2003). One such pro-
tein is X11/Mint, which is highly expressed
in neurons (King and Turner, 2004). X11
contains two postsynaptic density-95/
Discs large (DLG)/zona occludens-1
(PDZ) domains and one phosphotyrosine
interaction/PTB domain that interacts with APP (Zhang et al.,
1997). Yeast two-hybrid assays and studies in heterologous cells
show that APP and X11 interact and that deleting the PTB do-
main prevents these interactions (Borg et al., 1996; Zhang et al.,
1997; Sastre et al., 1998; Tomita et al., 1999). Similarly, in flies, it
has been demonstrated that APPL and theDrosophila homolog of
X11, dX11/dX11L, interact in vitro and in a yeast two-hybrid
assay (Hase et al., 2002). However, the ability of the proteins to
interact in an in vivo context has not been tested.
To determine whether dX11 and APPL interact in vivo and
whether dX11 might be involved in the FasII–APPL signaling
cascade that leads to new synaptic bouton formation, we gener-
ated polyclonal antibodies against the N-terminal amino acids
136–266 of dX11 for use in immunocytochemistry. Controls for
the specificity of this antibody included Western blot analyses of
body-wall muscles and S2 cell extracts showing that anti-dX11
recognized a band of the appropriate molecular weight, dsRNAi
in S2 cells, which eliminated immunoreactivity inWestern blots,
and overexpression of transgenic dX11, which increased immu-
noreactivity levels in tissue and Western blots (see below).
At wild-type NMJs, we found that dX11 was localized in
puncta at presynaptic boutons (Fig. 6A–E). Therefore, we per-
formed immunoprecipitations with anti-dX11 antibodies to de-
termine whether APPL exists in a complex with dX11 and FasII at
the body-wall muscles (Fig. 7A). Consistent with this notion, in
wild-type body-wall muscle extracts, immunoprecipitation with
dX11 antibodies coprecipitated endogenous APPL and FasII but
Figure 4. Microtubule tangles and abnormal APPL deposits are observed at NMJs of [FasII, APPL]-pre larvae. A–C, E–J, NMJs
fromwild type (A–C) and larvae overexpressing presynaptic FasII and APPL (E–J ) showing anti-Futsch (B, C, F, G, I, J ), anti-HRP
(A, C, E,G,H, J ), andmerged panels (C,G, J ).D, K, Anti-HRP and anti-tubulin in wild type (D) and [FasII, APPL]-pre (K ). Note the
disorganized appearance of Futsch andmicrotubules inmutant NMJs (K, arrow). Scale bar: (inK )A–C, E–J, 10m;D,K, 6.5m.
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failed to coprecipitate tubulin or spectrin,
demonstrating the specificity of the im-
munoprecipitation (Fig. 7A). When APPL
levels were enhanced using UAS–APPL,
the levels of APPL, but not of FasII, were
also enhanced in the dX11 immunopre-
cipitation. This suggested that FasII may
be included in the complex because of
its interactions with dX11 and not with
APPL. This possibility was addressed by
performing the immunoprecipitations in
the absence of APPL, in the Appl null mu-
tant, as well as from larvae expressing an
APPL variant lacking the GYENPTY se-
quence, the known site of interaction be-
tween dX11 and APPL. We found that, in
both situations, the coprecipitation of
FasII by dX11 was substantially increased,
suggesting that dX11 can interact with
FasII independent from APPL (Fig. 7A).
Furthermore, because the coprecipitation
between FasII and dX11 is stronger in the
absence of APPL, these results suggest that
APPL may negatively regulate the binding
between dX11 and FasII. We also con-
firmed that the interaction between APPL
and dX11 depended on the PTB domain in
vivo, as suggested previously by using the
yeast two-hybrid assay (Hase et al., 2002)
(Fig. 7B).
The above results suggest that FasII can
interact in vivowith dX11 in the absence of
APPL. However, the possibility exists that
FasII and APPL can additionally interact
independently of dX11. Because no dX11
null mutant is currently available (but see
below), this possibility was addressed by
transfectingDrosophila S2 cells. S2 cells ex-
press endogenous APPL and dX11 but vir-
tually no FasII (Fig. 7C, input). However,
we found that endogenous dX11 could be completely eliminated
by using dsRNA (Fig. 7C, input). To address the possibility that
APPL and FasII may interact with independence from dX11, we
transfected S2 cells with dX11 and FasII. In some of these exper-
iments, S2 cells were additionally treated with dX11 dsRNA to
eliminate endogenous dX11. We found that antibodies against
APPL strongly coprecipitated both FasII and dX11 in cells double
transfected with FasII and dX11, and no such coprecipitationwas
observed in untransfected cells (Fig. 7C). However, similar levels
of FasII were coprecipitated by APPL antibodies when cells were
treated with dX11 dsRNA, despite the dramatic reduction in
dX11 levels in treated cells (Fig. 7C). Because substantial residual
dX11 was still detected in the extracts despite dX11 dsRNA treat-
ment, we repeated these experiments in cells transfected with
only FasII, with the expectation that dsRNA would completely
eliminate endogenous dX11. We found that, in this case, dX11
dsRNA completely eliminated endogenous dX11, but FasII was
still coprecipitated (Fig. 7C). These results suggest that APPL and
FasII can also interact even in the absence of dX11.
These observations show that dX11 is present at the NMJ and
that it interacts with both APPL and FasII in vivo and in S2 cells.
To understand the significance of dX11 during NMJ expansion,
we used several approaches, including the characterization of a
hypomorphic dX11 mutant, the generation of transgenic flies
carrying full-length dX11 (UAS–dX11) to be used for gain-of-
function studies, and the generation of flies carrying a dX11
transgene lacking the APPL-binding PTB domain (UAS–
dX11PTB). In our coprecipitation experiments, we found that
the dX11PTB transgene reduced the interactions between dX11
and APPL (Fig. 7B). For the loss-of-function studies, we used a
strain carrying a P-element insertion 169 bp from the dX11 gene
transcription start (dX11P). Western blot analysis of body-wall
muscles from dX11P over a deficiency of the dX11 region,
Df(1)BK10, demonstrated that, in this mutant, there was a sub-
stantial decrease in dX11 signal, but the levels of FasII and APPL
were normal (Fig. 7D).
Notably, we found that overexpression of dX11 in motoneu-
rons resulted in a substantial increase in bouton number [Figs.
6G–I (arrowheads inH), 7E,F]. Like NMJs overexpressing FasII
presynaptically and postsynaptically, and overexpressing APPL
presynaptically, the increase in bouton number was primarily
attributable to an enhanced proliferation of buds (Fig. 6H, ar-
rowheads). The opposite phenotype, a decrease in bouton num-
ber, was observed in dX11P/Dfmutants (Fig. 7E,F). This pheno-
type is similar in extent to Appld mutants. In both transgenic
larvae and mutants, however, the size of the muscles was signifi-
Figure5. Electronmicroscopyof abnormal bouton structure in [FasII, APPL]-premutants.A–D,Midline cross-sections through
wild type (A) and [FasII, APPL]-pre (B–D) boutons. Note the presence of three groups of abnormal concentric rings (C, asterisks)
of internal membranes (C, arrowheads) in the mutant, the numerous presynaptic coated vesicles (B, arrowheads), and the large
number of postsynaptic vesicle-like structures (D, arrowheads). b, Bouton; SSR, subsynaptic reticulum; arrows point to presynap-
tic densities. Scale bar: (in C) A, C, 0.8m; B, D, 0.4m.
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cantly different from control. Therefore, for the quantification of
boutons, numbers were normalized by the muscle surface area
(Fig. 7F). To determine whether the increase in boutons in
[dX11]-pre depended on the presence of APPL, we expressed
dX11 in the Appl null mutant background. We found that the
increase in boutonnumber observed by dX11 overexpressionwas
not affected by the lack of APPL in Appld null mutant larvae,
suggesting that dX11 acts downstream of APPL (Fig. 7E,F).
Moreover, after presynaptic expression of dX11PTB, which
cannot interact with APPL, overproliferation of buds was not
observed, andNMJswere either indistinguishable fromwild-type
controls or had a significant increase in the number of mature
boutons depending on the strength of the UAS–dX11PTB used
(Fig. 7E,F). Furthermore, expressing dX11PTB completely
suppressed the increase in budding observed in [FasII]-pre-post
(Fig. 6L–N), demonstrating that dX11 acts downstream of FasII
[8.6 1.1 buds in wild type (n 30); 25.2 2.3 buds in [dX11]-
pre (n 14); 0.8 1.4 buds in [dX11PTB]-pre (n 10); 1.25
0.33 in dX11P/Df (n 16); 7.8 1.6 buds in [FasII, dX11PTB]-
pre-post (n  6)]. Thus, FasII requires both APPL and dX11 to
stimulate bouton budding.
Interestingly, in [dX11]-pre, the highest levels of dX11 immu-
noreactivity were observed in developing buds, which appeared
as protrusions at the edge of parent boutons (Fig. 6 I,F, arrows, J).
Conversely, in the case of presynaptic expression of dX11PTB,
no enrichment of dX11 was found at the presynaptic membrane,
and rather dX11PTB became abnormally localized within the
bouton cytoplasm (Fig. 6K,O).
The distribution of APPL was also al-
tered in dX11PTB and dX11P/Df (Fig. 8).
In wild type, APPL is found at very low
levels at the NMJ associated with the bou-
ton membrane and within the bouton cy-
toplasm (Torroja et al., 1999) (Fig. 8A,B).
Although anti-APPL immunoreactivity is
low at NMJs of wild type, this signal is
highly specific, because it is completely
suppressed in Appl null mutants (Torroja
et al., 1999). In dX11P/Df mutants, there
was an increase in the levels of APPL inside
the boutons, and APPL often appeared
there in large accumulations (Fig.
8F,G, J,K) (supplemental Fig. 2C, avail-
able at www.jneurosci.org as supplemental
material). This was even more evident in
NMJs expressing the dX11PTB con-
struct, which resulted in strong APPL ac-
cumulations inside all boutons (Fig. 8R–
S). In contrast, boutons had normal FasII
localization in all dX11 genotypes (Fig.
8C,D,H, I,L,M,P,Q,T,U).
Discussion
Here, we demonstrate that the ability of
FasII to function either as a permissive or a
restrictive influence on synapse growth de-
pends on a balance of FasII levels between
the presynaptic and postsynaptic cells.
Furthermore, we show that FasII and
APPL form a biochemical complex in vivo
and that the ability of FasII to promote
new synapse formation requires an APPL-
dependent transduction cascade. Finally,
we show that dX11 interacts with APPL in vivo and is involved in
APPL/FasII-dependent new synaptic bouton formation.
Role of APPL and FasII in promoting new synaptic
bouton formation
During the development of the larval NMJ, as muscles continu-
ously increase in size, synaptic efficacy is maintained in part by
the formation of new synaptic boutons (Packard et al., 2003). In
this process, FasII plays two fundamental roles: one of mainte-
nance, as exemplified in the absence of FasII, when synaptic bou-
tons begin to form but later retract, and a role in bouton prolif-
eration (Schuster et al., 1996a). Although the role of FasII in
synaptic maintenance might be related to its ability to mediate
cell adhesion between the presynaptic and postsynaptic mem-
branes, its ability to regulate budding mostly depends on genetic
interactions with APPL: in the absence of APPL, a symmetric
increase or decrease in FasII levels has no influence or even de-
creases bouton number. Although APPL is not absolutely re-
quired for synaptic growth, elimination of APPL results in signif-
icantly smaller arbors (Torroja et al., 1999).
We found that APPL was required for both FasII-dependent
synaptic growth and for many physiological abnormalities ac-
companying NMJ structural defects. Although the bouton num-
ber decrease inAppl null mutants was correlated with a decreased
amplitude of evoked synaptic responses, the bouton number in-
crease in fasIIe76/ was correlated with increased EJP amplitude.
This increase was suppressed (to Appld levels) by eliminating
APPL in fasIIe76/ mutants. In [FasII]-pre-post, however, the
Figure 6. dX11 and APPL are found in a complex at the NMJ, and changes in dX11 levels mimic changes in APPL levels. A–C,
G–I, L–N, Single confocal slices of NMJs stained with anti-dX11 (A, G, L), anti-HRP (B,H,M ), and merged panels (C, I, N ). A–O,
Specimens are wild type (A–E), larvae overexpressing dX11 presynaptically ([dX11]-pre; F–J ), and larvae expressing a dX11
variant missing the PTB domain ([PTB]-pre; K–O). D–F, J–K, O, High-magnification views of boutons from the above geno-
types, showing the localization of dX11 in each case. Note that, in wild type and [dX11]-pre, dX11 staining is enriched at the
presynaptic membrane (E, J ), but only in [dX11]-pre does the protein accumulate at sites of budding (F, arrow). K, In contrast, in
dX11PTB, dX11 immunoreactivity is observed within the bouton cytoplasm. I, F, Arrows point to buds accumulating dX11. H,
Arrowheads point to buds. Scale bar: (in O) A–C, G–I, L–N, 12m; D–F, J–K, O, 3m.
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dramatic increase in buds was correlated with an EJP amplitude
decrease, possibly because these boutons were buds or immature
boutons. Similarly, in [APPL]-pre, there was both an increase in
buds and a decrease in EJP amplitude. Remarkably, as seen in the
fasIIe76/mutants, the EJP phenotype is suppressed in the Appld
background (again, reaching Appld levels). Thus, as in the mor-
phological studies, many physiological abnormalities elicited by
changing FasII levels depended on APPL. Interestingly, Appld
does mimic many electrophysiological phenotypes reported pre-
viously in fasIIe76 homozygotes, in that both show increased
mEJP frequency, increased mEJP amplitude, and decreased bou-
ton number (Stewart et al., 1996).
Activation of the synapse-promoting activity of APPL by FasII
depended on simultaneous changes in the presynaptic and
postsynaptic cell, whereas a unilateral change in FasII in either
cell alone interfered with synapse formation. This may relate to
the ability of FasII to establish cis- and trans-homophilic interac-
tions and to the exclusive presynaptic expression of APPL (Luo et
al., 1990).
FasII signaling through APPL
A genetic interaction between Appl and fasII was clearly demon-
strated in our studies. We also demonstrated that both proteins
form an endogenous complex at the NMJ and that this complex
includes the APPL-binding protein dX11. In these interactions,
we found that FasII could independently interact with bothAPPL
and dX11. In the absence of APPL, an interaction between dX11
and FasII was maintained, whereas in the absence of dX11, inter-
actions between APPL and FasII were preserved. Precisely how
APPL and FasII proteins interact physically remains unclear.
However, we found that, as was the case for APPL, the FasII
intracellular domain was essential for the budding phenotype,
suggesting that they may interact through their intracellular
domains (Torroja et al., 1999). In the case of FasII and dX11,
FasII contains a PDZ-binding motif, which interacts with
PDZ1–PDZ2 domains of DLG (Thomas et al., 1997). It is
possible that PDZ domains of dX11 are alternative FasII-
interacting domains.
Figure 7. FasII stimulates NMJ expansion by a mechanism that requires both APPL and dX11, and dX11 exists in the APPL–FasII complex. A, Antibodies against dX11 were used to immunopre-
cipitate dX11 from body-wall muscles of wild type, APPL gain- and loss-of-function mutants, and a strain expressing APPL but lacking the dX11-interacting domain (APPLCi). The blot was
sequentially blotted with antibodies against dX11, APPL, FasII, spectrin (Spec), and tubulin (Tub). B, Anti-dX11 antibody was used to immunoprecipitate dX11 from body-wall muscle extracts of
larvae expressing a full-length dX11 and larvae expressing dX11 lacking the APPL interaction domain (dX11PTB) and sequentially probed with antibodies against dX11, APPL, and tubulin. C,
Antibodies against APPLwere used to immunoprecipitateAPPL fromDrosophila S2 cells expressing FasII and/or dX11. In some cases, cellswere also treatedwith dX11dsRNA. Blotswere sequentially
probed with antibodies against APPL, FasII, and dX11. D, Western blots of body-wall muscle extracts from wild-type and dX11P/Df larvae probed with antibodies against dX11, APPL, FasII, and
tubulin.E, Thehistogramshows the total number of boutons atmuscles 6 and7 (abdominal segment 3) of third instarwild type, FasII, APPL, anddX11genetic variants.F, Boutonnumbers havebeen
normalized by muscle surface area. The number of samples quantified in E is as follows: wild type, n 95; Appld, n 49; [FasII]-pre-post, n 13, [dX11]-pre, n 8; Appld, [dX11]-pre, n 13;
[PTB], n 14; [PTB]#, n 10; [PTB]-pre-post, n 8. The number of samples quantified for F is as follows: wild type, n 30; Appld, n 23; [FasII]-pre-post, n 13, [dX11]-pre, n 14;
Appld, [dX11]-pre, n 13; [PTB], n 14; [PTB]-pre-post, n 8; dX11P/Df 16. *p	 0.05; ***p	 0.0001. Error bars represent SEM.
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Role of dX11 in FasII–APPL-modulated synaptic growth
Our studies have identified a third member of the transduction
cascade that promotes synaptic growth, dX11. First, dX11 was
found in the same complex with APPL at the body-wall muscles,
and the lack of the GYENPTY sequence of APPL or the PTB
domain of dX11 suppressed or dramatically reduced this interac-
tion, respectively. Second, a presynaptic increase of dX11 expres-
sion mimicked the effects of upregulating APPL. This effect was
suppressed by deleting the PTB domain. Third, deleting the
dX11–APPL interaction sequence in dX11 (dX11PTB) mim-
icked the effect of deleting the APPL–dX11 interaction sequence
(APPLCi) at the NMJ. Fourth, the effects of FasII gain-of-
function in both the presynaptic and the postsynaptic cell were
suppressed by expressing dX11PTB, suggesting that the APPL
and dX11 interaction is required for the effect of FasII. Finally, a
hypomorphic dX11 mutant mimicked the effects of eliminating
APPL during NMJ expansion.
A variety of proteins that bind to theGYENPTY region of APP
either increase APP translocation to the cell surface or alter the
stabilization or cleavage of APP at the cell surface (Sabo et al.,
1999; Taru et al., 2002). In particular, mammalian X11/Mint is
highly expressed in neurons and interacts with the APP GY-
ENPTY sequence through its single PTB domain (King et al.,
2003). Neuronal X11 also associates directly with the exocytotic
protein Munc-18, which in turn interacts with syntaxin1A (Bie-
derer and Sudhof, 2000; Graham et al., 2004). In our studies, we
found that deleting the APPL interaction domain in dX11 re-
sulted in large accumulations of APPL within boutons, suggest-
ing that dX11 may be involved in trans-
porting or facilitating the insertion of
APPL into the presynaptic membrane.
Several studies suggest that APPL be-
haves as a Go-protein-coupled receptor
(Okamoto et al., 1995; Brouillet et al.,
1999). Go has been shown to be involved in
microtubule polymerization (Wang and
Rasenick, 1991; Wu et al., 2001), suggest-
ing that one of the actions of APPL during
NMJ expansion might be to regulate the
cytoskeleton. Recent studies show thatmi-
crotubule dynamics at theDrosophilaNMJ
are essential for bud maturation and ex-
tension (Ruiz-Canada et al., 2004). Based
on these known interactions, the following
model for APPL and dX11 function can be
proposed (Fig. 8E). Trans-homophilic in-
teractions between FasII molecules local-
ized at the presynaptic and postsynaptic
cell activate the binding between the dX11
complex (containing exocytic molecules)
andAPPL (Fig. 8Ei–Eiii). dX11 then trans-
ports its partners to sites of FasII-mediated
cell adhesion (Fig. 8Eiv). This results, on
one hand, in the transport of the exocytic
machinery and perhaps the addition of
new membrane to sites of budding. In
contrast, the insertion of APPL into the
presynaptic membrane and its interac-
tions with FasII activate Go, resulting in
the stimulation of microtubule polymer-
ization, which is required for bud exten-
sion (Fig. 8Eiv).
The notion that FasII might function
not only as a cell adhesion molecule but also as a signaling mol-
ecule is not without precedence (for review, see Packard et al.,
2003). Indeed, the mammalian FasII homolog NCAM has been
shown to initiate a signal transduction cascade after activation of
both nonreceptor tyrosine kinases (nRTKs) and RTKs that may
influence neurite outgrowth (Beggs et al., 1997). Interestingly, a
genetic interaction between fasII and the nRTK Abelson tyrosine
kinase gene (Abl) has been reported previously in flies (Garcia-
Alonso et al., 1995), and, in mammals, activated Abl interacts
directly with and phosphorylates the APP intracellular GY-
ENPTY sequence (Zambrano et al., 2001; Perkinton et al., 2004).
A variety of kinases are able to phosphorylate the APP cytoplas-
mic domain, resulting in regulation of APP metabolism and
function (Aplin et al., 1996; Ando et al., 2001; Inomata et al.,
2003; Standen et al., 2003). Phosphorylation of Thr668 of
APP695 serves as a molecular switch that appears to regulate X11
binding to APP (Ando et al., 2001; Taru and Suzuki, 2004). Thus,
phosphorylation of APPL could be the switch that leads to dX11
binding and subsequent translocation of APPL to the presynaptic
membrane in the Drosophila NMJ.
APPL function and Alzheimer’s disease
Our studies show that an asymmetric increase in FasII at the
presynaptic cell interferes with normal synaptic bouton forma-
tion. This is characterized by formation of grossly abnormal bou-
tons containing internal membrane structures with unusual
APPL deposits and microtubule tangles surrounding these de-
posits. These internal APPL accumulations within the boutons
Figure 8. The localization of APPL at synaptic boutons is disrupted in dX11mutants and amodel of likely interactions between
FasII, dX11, and APPL during bouton budding.A–D, F–U, Single confocal slices of representative boutons stainedwith anti-APPL
(A, F, J,N, R), anti-APPL and anti-HRP (B, G, K, O, S), anti-FasII (C,H, L, P, T ), and anti-FasII and anti-HRP (D, I,M, Q, U ), in wild
type (A–D), dX11P/Df (F–K ), Appld (L,M ), [dX11]-pre (N–Q), and [dX11PTB]-pre (R–U ). Note that APPL is found at very low
levels at the NMJ of wild type. In dX11mutants and in boutons from larvae overexpressing dX11PTB, there are large internal
accumulations of APPL. FasII staining changes little, if any, among the various dX11 specimens. Scale bar, 3.5m. E, Diagram
depicting likely interactions between FasII, APPL, and dX11 during bouton budding (see Discussion). Eii, Homophilic binding
between FasII molecules at opposing sides of the synapse triggers the activation of APPL, an event thatmay involve its phosphor-
ylationby the tyrosine kinaseAbl.Eiii, APPLphosphorylation allowsbinding to thePTBdomain of dX11,whichbrings or facilitates
the insertion of APPL into the presynaptic membrane. dX11 also binds members of the exocytic machinery, thus bringing these
components to the budding bouton. In addition, binding of APPL to FasII activates Go protein, which modulates the microtubule
cytoskeleton required for bud extension.
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seem reminiscent of intraneuronal amyloid- accumulation,
which may precede extracellular amyloid plaque formation in
Alzheimer’s disease (D’Andrea et al., 2001; Glabe, 2001; Taka-
hashi et al., 2002; Oddo et al., 2003). This phenomenon may
provide additional clues toward a mechanism by which interfer-
ence with normal APP function could lead to pathological events
and subsequent symptoms of Alzheimer’s disease.
In conclusion, we demonstrated via genetic analysis that
APPL, FasII, and dX11 are involved in the same pathway that
regulates synaptic expansion at the Drosophila NMJ. Altogether,
these results suggest that beyond a role in cell adhesion, FasII-
mediated signaling depends on a precise balance of its levels of
expression at the presynaptic and postsynaptic cell and is likely to
activate intracellular transduction pathways that control synapse
structure.
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